Carilion Clinic Retirement Plan

Carilion Clinic Retirement Plan

The Carilion Clinic Retirement Plan exists to provide retirement benefits for the employees of Carilion Clinic, a Roanoke, Virginia-based not-for-profit healthcare system that operates seven hospitals and serves over one million residents across western Virginia. The plan is overseen by Carilion Clinic's investment office, led by Vice President and Chief Investment Officer Fred Greear, who reports to Executive Vice President and CFO Donald B. Halliwill. Carilion itself traces its roots to 1899, though the retirement plan's founding date is not publicly disclosed. The system's structure as a not-for-profit integrated delivery network — combining clinical care with the Virginia Tech Carilion School of Medicine, a joint venture with Virginia Tech — makes this a single-employer plan tied to an academic-medical anchor, with a stable participant base unlikely to experience dramatic inflow or outflow shocks. The plan's investment strategy, as reflected in public pension disclosures and manager meeting records, concentrates heavily on private equity buyout strategies. Greear has built a portfolio that favors mid-market and large-cap buyout funds, with additional allocations to growth equity and venture capital. The plan does not disclose its full portfolio publicly, but manager relationships confirmed through institutional investor events and consultant databases include commitments to funds managed by firms such as Hellman & Friedman, Advent International, and Leonard Green & Partners. Geographically, the portfolio is overwhelmingly US-focused, with limited exposure to developed Europe and no known dedicated emerging markets sleeve. The plan accesses private markets exclusively through fund commitments, not direct co-investments or separate accounts. The size of the plan's total assets is not publicly disclosed, and neither Greear nor Carilion's finance leadership has given media interviews specifying AUM. Greear was named a finalist for Institutional Investor's Small Endowment/Foundation Investment Officer of the Year, a recognition that suggests the plan operates at a scale comparable to mid-sized US foundations and endowments, likely in the $500 million to $2 billion range based on peer institutional comparisons — though this remains an Altss estimate. Carilion Clinic itself maintains a related philanthropic entity, the Carilion Clinic Foundation, which is a legally separate 501(c)(3) organization supporting patient care, research, and education. No club memberships such as Tiger 21 or R360 have been disclosed for the investment team. The plan's structural differentiator is its posture as a liquidity-absorbent buyer inside a liability structure that behaves more predictably than a corporate pension's. Carilion's workforce is concentrated in a single region with low employee turnover, and its not-for-profit status shields the plan from the quarterly earnings pressures that shape risk appetite at publicly traded corporate sponsors. This allows Greear to commit patient capital to closed-end buyout funds without the liquidity-management gymnastics required of more volatile corporate plans — a genuine structural advantage in private equity.